Premium
An 18-month-old equity deal that a distressed assets fund set up jointly by Bain Capital Credit and Piramal Enterprises Ltd struck with a pharmaceuticals company has come unstuck. India Resurgence Fund, the Bain-Piramal joint venture, had in April last year agreed to invest up to $144 million (Rs 992 crore) in ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
